Steroid-Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials

G. B. Klintmalm*, F. Vincenti, A. Kirk

*Corresponding author for this work

Research output: Contribution to journalEditorial

7 Scopus citations
Original languageEnglish
Pages (from-to)3077-3078
Number of pages2
JournalAmerican Journal of Transplantation
Volume16
Issue number11
DOIs
StatePublished - 1 Nov 2016
Externally publishedYes

Keywords

  • clinical trial design
  • editorial/personal viewpoint
  • guidelines
  • immunosuppressant
  • immunosuppression/immune modulation

Fingerprint

Dive into the research topics of 'Steroid-Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials'. Together they form a unique fingerprint.

Cite this